Hellstrand, K.

patient genotype treatment hepatitis study hepatitis c steatosi baseline liver virus therapy response infection decline ribavirin outcome phase stage level score allele il 28b treatment outcome hcv rna guci score ishak cirrhosis hepatitis c virus brosi university rs 12979860 -10 hcv genotype 1 signi association group fibrosis table fi brosis genotype 1 interferon phase decline concentration hcv-rna model ficant biopsy ip -10 rs 8099917 hepatology index polymorphism il 28b polymorphisms kinetic value rs 12980275 hcv infection body mass index result disease carrier plasma signi ficantly 0.33 journal fi brosis stage fi rst phase hepatology 2011 vol hcv genotype 2 day 29 peginterferon baseline ip -10 24 weeks figure westin count nonresponder il 28b snps il 28b variants reduction